Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Blueblood Ventures Ltd (539637)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 539637 NSE: Finance - Stock Broking | Small Cap | Blueblood Ventures Share Price
₹11.07 0.00 (0.00%)
As on 29-May'23 18:02
Blueblood Ventures Ltd (539637)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 539637 NSE: Finance - Stock Broking | Small Cap | Blueblood Ventures Share Price
₹11.07 0.00 (0.00%)
As on 29-May'23 18:02
Key Metrics
Valuation Multiples
Market Cap
₹3 Cr.
Current Price
₹11.1
52-Week Low / High
₹11 / 11
TTM EPS
₹0.6
TTM Sales
₹2.6 Cr.
Book Value per Share
₹50.7
P/E Ratio
19.45
Lower than its 5-year historical median
Industry PE
46.8
Price to Book (P/B)
0.22
Lower than its 3-year historical median
Price to Sales (P/S)
1.29
Lower than its 5-year historical median
EV/EBITDA
26.88
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
1.13%
Return on Capital Employed (ROCE)
3.56%
Return on Assets (ROA)
0.12%
Operating Profit Margin
164.7%
Net Profit Margin
6.64%
Gross Profit Margin
11.1%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
-1.96%
Operating Profit Growth (1 Year)
-
-60.41%
Net Profit Growth (1 Year)
-
41.67%
Asset Quality
Promoter Holding
53.12%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹12 Cr.
Equity
₹3 Cr.
Face Value
₹10
All Time Low / High
₹5.42 / 75.20
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Blueblood Ventures Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 13.5% | 3.2% | 2.5% | -0.2% | -3% | -0.7% | 0% | 0% | 0% | 0.1% | - |
| Value Creation Index ⓘ | 0.0 | -0.8 | -0.8 | NA | NA | NA | -1.0 | -1.0 | -1.0 | -1.0 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0.6 | 2.6 | 59.7 | 0.6 | 2.2 | 0.5 | 0.7 | 0.1 | 0.5 | 0.5 | 0 |
| Sales YoY Gr. | - | 314.5% | 2,222.2% | -99% | 279.3% | -79.1% | 41.3% | -83.1% | 363.6% | -2% | - |
| Adj EPS ⓘ | 0.4 | 0.7 | 1 | -0.7 | -9.5 | -2.2 | 0.1 | 0.1 | 0.1 | 0 | 0.1 |
| YoY Gr. | - | 65.9% | 48.5% | -170.3% | NA | NA | NA | -14.3% | 33.3% | -75% | - |
| BVPS (₹) ⓘ | 50.3 | 50.9 | 15.5 | -15.4 | -17.1 | -16.7 | -16.6 | -19.2 | -18.7 | -18.7 | 9.4 |
| Adj Net Profit ⓘ | 0.1 | 0.2 | 0.3 | -0.2 | -2.9 | -0.7 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Ops. ⓘ | -59.8 | -5 | 130 | -11.5 | -5.9 | -0.9 | -1.4 | -0.7 | -7.1 | -3.2 | - |
| Debt/CF from Ops. ⓘ | -1.7 | -28.4 | 1.1 | -8.2 | -15.9 | -105.3 | -68.9 | -141.6 | -13.3 | -30.2 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -2.4% | -25.7% | -8.4% | -2% | ||||
| Adj EPS ⓘ | -28.5% | NA | -34.1% | -75% | ||||
| BVPSⓘ | -189.6% | NA | NA | NA | ||||
| Share Price | -12.9% | 5% | - | - | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 1.1 | 1.4 | 3 | -2501.9 | 0 | 0 | 0 | 0 | 0 | 0 | -1.3 |
| Op. Profit Mgn % ⓘ | 1730.9 | 166 | 7.3 | -54.6 | -111.3 | -140.9 | -0.9 | -28.8 | 2.1 | -37.3 | NAN |
| Net Profit Mgn % ⓘ | 20 | 8 | 0.5 | -36.8 | -129.6 | -142.8 | 3.2 | 16.5 | 4.8 | 1.2 | 16.4 |
| Debt to Equity ⓘ | 6.6 | 9.3 | 29.6 | -20.4 | -18.3 | -18.8 | -18.8 | -16.4 | -16.7 | -17.3 | - |
| Working Cap Days ⓘ | 58,637 | 20,527 | 887 | 46,639 | 2,258 | 14,775 | 10,840 | 69,185 | 25,020 | 45,724 | 0 |
| Cash Conv. Cycle ⓘ | 56,010 | 19,746 | 446 | 290 | 178 | 1,314 | 1,045 | 14,475 | 8,026 | 13,642 | 0 |
Valuation of Blueblood Ventures - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'16 | Mar'17 |
|---|---|---|
| Income + | 0.76 | 2.73 |
| Exceptional Items ⓘ | 0.14 | 0.15 |
| Expenditure ⓘ + | 0.58 | 2.47 |
| Exceptional Items ⓘ | 0 | 0 |
| Profit Before Tax ⓘ | 0.18 | 0.26 |
| Taxes ⓘ | 0.06 | 0.09 |
| Profit After Tax | 0.12 | 0.17 |
| Adjusted EPS (₹) | 0.4 | 0.6 |
| Dividend Payout Ratio (%) | 0% | 0% |
| PARTICULARS | Mar'16 | Mar'17 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Equity Capital + | 15.10 | 15.23 | ||||||||
| Short term borrowings | 0.02 | 0 | ||||||||
| Long Term Borrowings | 100.14 | 114.73 | ||||||||
| Current Liabilities | 22.32 | 28.26 | ||||||||
| Trade Payables | 0.08 | 0.07 | ||||||||
| Other Liabilities | -0.10 | -0.07 | ||||||||
| Total Liabilities ⓘ | 137.56 | 158.22 | ||||||||
Assets | ||||||||||
| Non Current Asset + | 0.21 | 5.84 | ||||||||
| Current Asset + | 137.36 | 152.37 | ||||||||
| Total Assets ⓘ | 137.56 | 158.22 | ||||||||
| PARTICULARS | Mar'16 | Mar'17 |
|---|---|---|
| Cash Flow From Operating Activity ⓘ | -59.78 | -5 |
| Cash Flow From Investing Activity ⓘ | 0.01 | -5.52 |
| Cash Flow From Financing Activity ⓘ | 59.38 | 10.44 |
| Net Cash Flow ⓘ | -0.39 | -0.07 |
| PARTICULARS | Mar'16 | Mar'17 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Operational & Financial Ratios | ||||||||||
| EPS (₹) | 0.40 | 0.60 | ||||||||
| DPS (₹) | 0 | 0 | ||||||||
| BVPS (₹) | 50.3 | 50.7 | ||||||||
Performance Ratios | ||||||||||
| ROA (%) | 0.1 | 0.1 | ||||||||
| ROE (%) | 0.8 | 1.1 | ||||||||
| ROCE (%) | 9.4 | 3.6 | ||||||||
Valuation Parameters | ||||||||||
| Price/Book(x) | 0.7 | 0.8 | ||||||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Blueblood Ventures Ltd FAQs
The current trading price of Blueblood Ventures on 29-May-2023 18:02 is ₹11.07.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-May-2023 the market cap of Blueblood Ventures stood at ₹3.32 Cr
The latest P/E ratio of Blueblood Ventures as of 28-May-2023 is 184.6.
The latest P/B ratio of Blueblood Ventures as of 28-May-2023 is 1.18.
The 52-week high of Blueblood Ventures is ₹11.07 and the 52-week low is ₹11.07.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Blueblood Ventures is ₹0.11 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Blueblood Ventures Ltd is a below average quality company.
The key valuation ratios of Blueblood Ventures Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
No data found
About Blueblood Ventures Ltd
No data to display
You have 44 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
